Andrew Fischer to Biomarkers, Tumor
This is a "connection" page, showing publications Andrew Fischer has written about Biomarkers, Tumor.
Connection Strength
1.099
-
Harris T, Sheel A, Zong Y, Hutchinson LM, Cornejo KM, Bubendorf L, Yates J, Fischer AH. Cytologically targeted next-generation sequencing: a synergy for diagnosing urothelial carcinoma. J Am Soc Cytopathol. 2021 Jan-Feb; 10(1):94-102.
Score: 0.550
-
Yantiss RK, Cosar E, Fischer AH. Use of IMP3 in identification of carcinoma in fine needle aspiration biopsies of pancreas. Acta Cytol. 2008 Mar-Apr; 52(2):133-8.
Score: 0.229
-
Li C, Zota V, Woda BA, Rock KL, Fraire AE, Jiang Z, Lu D, Xu B, Dresser K, Lutman CV, Fischer AH. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations. Mod Pathol. 2007 Dec; 20(12):1263-8.
Score: 0.222
-
Fischer AH. Circulating tumor cells: seeing is believing. Arch Pathol Lab Med. 2009 Sep; 133(9):1367-9.
Score: 0.064
-
Sun T, Akalin A, Dresser K, Fischer AH, Zuo T. The Utility of MYB Immunohistochemistry (IHC) in Fine Needle Aspiration (FNA) Diagnosis of Adenoid Cystic Carcinoma (AdCC). Head Neck Pathol. 2021 Jun; 15(2):389-394.
Score: 0.034